Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Femoral head decompression relieves SCD hip pain

Key clinical point: Core decompression with bone marrow aspirate concentrate (CD+BMAC) produced clinically significant improvements in pain and function in sickle cell patients, versus core decompression (CD) alone.

Major finding: Among the CD+BMAC patients, pain scores declined two points on average, from 6 preoperatively to 4 postoperatively.

Study details: Single-center study of 35 hips in 29 sickle cell disease patients with an average of 3.6 years of follow-up.

Disclosures: Dr. Fornari reported having no financial disclosures.

Citation:

Fornari ED et al. FSCDR 2019, Abstract JSCDH-D-19-00004.